Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. (Q55041970)

16 June 2018

title

Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. (English)

1 reference

16 June 2018

0 references

0 references

0 references

Weiss L

1

1 reference

16 June 2018

Zeira M

2

1 reference

16 June 2018

Reich S

3

1 reference

16 June 2018

Har-Noy M

4

1 reference

16 June 2018

Mechoulam R

5

1 reference

16 June 2018

Slavin S

6

1 reference

16 June 2018

Gallily R

7

1 reference

16 June 2018

publication date

1 March 2006

1 reference

16 June 2018

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Autoimmunity

1 reference

16 June 2018

volume

39

1 reference

16 June 2018

issue

2

1 reference

16 June 2018

page(s)

143-151

1 reference

16 June 2018

Cannabinoids in pain and inflammation

cites work

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Cannabinoid receptors and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

The cannabinoid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Delta 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Controlled clinical trial of cannabidiol in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Allogeneic cell-mediated immunotherapy of leukemia with immune donor lymphocytes to upregulate antitumor effects and downregulate antihost responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Genetic control of autoimmune diabetes in the NOD mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

NOD mouse colonies around the world--recent facts and figures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

The expression of cytokine genes in the peritoneal macrophages and splenic CD4- and CD8-positive lymphocytes of the nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Insulin-secretory-granule specific T cell clones in human IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

In vivo activity and in vitro specificity of CD4 Th1 and Th2 cells derived from the spleens of diabetic NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Translating data from animal models into methods for preventing human autoimmune diabetes mellitus: caveat emptor and primum non nocere

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Effects of Cyclosporine Immunosuppression in Insulin-Dependent Diabetes Mellitus of Recent Onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

T-Cell Subsets: Who does the polarizing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Immune deviation towards Th2 inhibits Th-1-mediated autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Th1 and Th2 CD4 T cells in the pathogenesis of organ-specific autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Insulin selectively primes Th2 responses and induces regulatory tolerance to insulin in pre-diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

Isolation and structure of .DELTA. - tetrahydrocannabinol and other neutral cannabinoids from hashish

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930500356674

10.1080/08916930500356674

21 January 2018

Identifiers

DOI

1 reference

16 June 2018

1 reference

16 June 2018